The intellectual property department at Jones Day has a formidable patent litigation team, with impressive strength and expertise in proceedings in district and federal courts, the International Trade Commission, the Patent Trial and Appeal Board, and arbitrations. The team frequently acts on global IP-related disputes in conjunction with the firm’s global network. Numerous leading pharma and life sciences rely on the team’s expertise, including Hope Pharmaceuticals, Johnson & Johnson, NXP Semiconductors, and Purdue Pharma L.P. In line with an increasing volume of work, the size of the team continues to increase, with the arrival in Silicon Valley of Jennifer Bennett from Dentons in March 2022. Anthony Insogna is the global IP practice leader, based in the firm’s San Diego office, with extensive experience representing pharma and biotech companies. In 2022, Insogna notably led on the victory for Toolgen, related to the Nobel-prize-related CRISPR-Cas9 gene-editing technology. David Maiorana co-heads the team, operating out of Cleveland. New York-based Sarah Geers is a key figure in the team, frequently representing innovative pharmaceutical companies in patent litigation proceedings.

The intellectual property practice at Kirkland & Ellis LLP has extensive experience representing clients across the country in front of the Court of Appeals for the Federal Circuit, the International Trade Commission, and the Patent Trial and Appeal Board. The team maintains a focus on trial strategy from the beginning to the end of a case, regularly protecting clients’ IP interests at the appellate level, and acts on precedent-setting cases for high-profile cases. Adam Alper is a notable member of the team, acting out of the team’s San Francisco office. Based in Los Angeles, Michael De Vries is another key name, with experience representing clients in a wide range of high-value intellectual property-related matters. Gregory Arovas and Gregg LoCascio are both key names in the group; the former, the practice head out of the New York office, and the latter, a leader of the Washington DC office.

The patent litigation team at Latham & Watkins LLP  offers expertise across cross all aspects of intellectual property, evidenced by an impressive history of success for Fortune 100 and numerous blue-chip companies. The team is well-integrated and highly capable of handling complex disputes across jurisdictions, in district and federal court, the International Trade Commission, and the Patent Trial and Appeal Board. With experience across industries, the team regularly acts for major pharma companies, including Amgen, Biogen, Johnson & Johnson, Abbott Laboratories, Regeneron, and Eagle Pharmaceuticals. David Callahan from the firm’s Chicago office is the global chair of the practice, regularly acting as a first-chair trial lawyer. The global vice chairs include Tony Sammi in New York, Jeff Homrig in Austin, and Jennifer Barry in San Diego. In Silicon Valley, Douglas Lumish is a key lawyer in the team, frequently acting on high-profile and precedent-setting matters. Maximilian Grant and Matthew J. Moore in Washington DC are both integral figures, with extensive experience.

The full-service intellectual property practice at Paul Hastings LLP routinely advises clients on complex IP matters, with comprehensive patent litigation capabilities. With expertise in both life sciences and tech, the team frequently represents many international innovative life sciences companies in high-value patent cases. The already impressive client roster of the team, boasting the likes of BioNTech, Samsung Electronics Co, Chevron, and L’Oréal, continues to grow, with the addition of major names such as Bloom Energy and Stanley Black & Decker Inc during 2022. The team has a strong bench of technical knowledge, led by Bruce Wexler and Eric Dittmann in New York, and Naveen Modi in Washington DC. Andrea Roberts joined the firm’s Palo Alto office, moving from Quinn Emanuel Urquhart & Sullivan, LLP in February 2022. Other prominent attorneys include Isaac Ashkenazi in New York, and both Phillip Ou and senior associate David Okano in Palo Alto.

The intellectual property practice at WilmerHale acts for domestic and international clients, frequently providing innovative solutions spanning trademark, copyright, patent drafting and prosecution, post-grant proceedings, and strategic IP portfolio development. Attorneys in the team have tech transfer and licensing, litigation, and due diligence experience, and also benefit from expertise in the team beyond the United States to other jurisdictions, frequently working with lawyers in the United Kingdom, Germany, and China. The strength of the team is demonstrated through their impressive client list, boasting the likes of Twitter, Sony, Meta Platforms, Hulu, and Bristol-Myers Squibb. Lisa Pirozzolo and Mark Selwyn co-chair the firm’s IP litigation practice, operating out of Boston and Palo Alto respectively, alongside Amy Wigmore, based in Washington DC, where Brittany Amadi is another key lawyer. Emily Whelan in Boston is the chair of the general IP department, focusing on litigation related to chemistry, biotech, and pharma. Boston-based William Lee remains a key figure in the team, with Palo Alto's Sonal Mehta has vast experience in high-stakes patent and tech disputes.

The patent litigation team at DLA Piper LLP (US) is widely renowned for representing a wide range of international tech and medical device companies, with a talented group of first-chair trial lawyers. The practice has seen significant growth across specific expansion areas including Austin, Washington DC, and Delaware. The team has impressive cross-jurisdictional capabilities, recently acting for Honeywell in the US ITC, Western District of Texas, German, the UK, China, and Delaware. The team leadership consists of Sean Cunningham and Erin Gibson from the firm’s San Diego office, Erin Gibson and Helena Kiepura operating out of Washington DC, Matthew Satchwell in Chicago, and Michael Sitzman in Silicon Valley.

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is a full-service intellectual property firm, with expertise in all aspects of IP law across patent, trademark, and copyright law. The experience of the mega-boutique spans most industries and technologies, from biotech, biologics, and biosimilars to semiconductors, FinTech, blockchain, Internet of Things, and many others. In addition to vast expertise in American patents and trademarks, the team has in-depth knowledge of European patents and trademarks. Members of the practice have degrees in scientific disciplines, with many having previously worked in a wide range of industries. Prominent clients of the practice include AstraZeneca, Biogen, BMW, FedEx, Samsung Electronics, and Siemens. All based in Washington DC, John M. Williamson, Erika Arner, and Anand Sharma co-head the team.

 

 

The intellectual property group at Gibson, Dunn & Crutcher LLP is highly adept at handling high-value and complex cases, frequently representing pharma companies in cases involving billion-dollar drugs and using the wide range of technical expertise available in the team to excel in telecoms-related cases. The group works closely with the appellate and constitutional law group at the firm, with appellate litigators often brought into develop legal strategy. The firm counts a number of household names as clients including Fitbit, Dell, Pfizer, AT&T, SoundCloud, and SharkNinja. All based in New York, Jane Love, Kate Dominguez, and Josh Krevitt all co-chair the intellectual property practice, alongside Ernest Hsin, operating out of the San Francisco office. The team continues to grow, with Charlotte Jacobsen joining the New York office from Ropes & Gray LLP in April 2022.

The intellectual property litigation team at Irell & Manella LLP litigates patents covering all types of techn, including software, visual effects, biotech, pharma, semiconductors, medical products, telecoms, and e-commerce, amongst others. The team handles both domestic and global patent litigation, often acting across Europe and Asia in addition to the US. The last year notably saw the team secure a $2.3bn final judgment for VLSI Technology against Intel. Kathleen O’Malley, recently a judge on the US Court of Appeals for the Federal Circuit joined the firm in May 2022, expanding its expertise. Los-Angeles based IP litigator Morgan Chu leads the team, having acted on precedent-setting patent-related matters for many years. Andrei Iancu, based in Washington DC and Los Angeles, the former director of the US Patent and Trademark Office is another key figure in the team. In Los Angeles, Benjamin Hattenbach, Jonathan Kagan, and Jason Sheasby are all integral to the practice.

Morrison Foerster‘s intellectual property litigation practice combines patent counseling with litigious prowess, providing clients with an integrated global service. The firm continues to expand, opening an office in Austin in 2022, while the acquisition of litigation boutique Durie Tangri LLP, led by standout figure Daralyn Durie, further strengthened the team. The group has strengths across all sectors, particularly in life sciences and tech, and has recently secured one of the largest settlements awarded in a life sciences patent case for Chugai. Notably, the team has also secured victories for Seagen Inc, Spotify, VMware, Xilinx, Target, and Intel Corporation. Richard Hung in San Francisco leads the team alongside Bita Rahebi in Los Angeles and Mark Whitaker in Washington DC. Michael Jacobs, based in San Francisco, is another key figure in the team.

The intellectual property department at Quinn Emanuel Urquhart & Sullivan, LLP has a successful record in representing major clients, including Samsung, Qualcomm, Janssen Pharmaceuticals, Olaplex, and Voxer. The team recently represented Allergen in consolidated Hatch-Waxman litigation and was successful in a $6bn dollar deal, which further gives their client patent protection through to the early 2030s. The team’s leadership spans several cities, with Charles Verhoeven and Sean Pak both operating out of San Francisco, Edward DeFranco in New York, and Dave Nelson in Chicago, alongside Californian-based attorneys Victoria Maroulis and Tigran Guledjian in Silicon Valley and Los Angeles respectively.

The patent litigation team at Williams & Connolly LLP is particularly well-versed in biologics, often acting on high-profile biosimilar litigation, with an additional growing expertise in tech. Key names such as Pfizer, Google, Samsung, and AstraZeneca are all notable clients of the team, with the team notably representing AstraZeneca in litigation against Merck Sharp & Dohme, Bristol-Myers Squibb Co, Aether Therapeutics, and a generic pharmaceutical defendant. Based in Washington DC, David Berl and Jessamyn Berniker co-head the team, with the former focusing primarily on the biotech, pharma, and energy fields, and the latter with broad experience across the pharma, biotech, electronic, mechanical, digital media, and medical device industries. Also in Washington, Thomas Selby, Dov Grossman, and Stanley Fisher are key figures in the team, all with extensive first-chair experience.

The intellectual property practice at Winston & Strawn LLP acts across patent litigation, regularly representing companies in the tech and pharma sectors, offering patent knowledge covering semiconductor design, consumer electronics, wired and wireless networking, industrial machinery, and telecom standards, among others, supported by a number of key team members with technical degrees. The expertise of the team further lies in handling litigation before the Patent Trial and Appeal Board. In line with the increase in ITC and district court proceedings, the practice continues to expand, with the arrival of Barry Shelton and Bradley Coburn from Shelton Coburn in Dallas, Brian Ferguson and Robert Vlasis formerly of Weil, Gotshal & Manges LLP in Washington DC, and Ryuk Park from video-game company Krafton Inc in California. David Enzminger and Nimalka Wickramasakera co-head the practice, operating out of the firm’s Los Angeles office. Chicago-based George Lombardi is vastly experienced in patent trials as a first-chair attorney.

The patent litigation team at Arnold & Porter frequently represents Fortune 500 companies and major industry players including Crocs, Google, Adobe, Nike, and Pfizer. 2022 saw the Federal Circuit rule in favor of the firm on behalf of Hologic, after the team prevailed the year previously on the matter of assignor estoppel in the Supreme Court. Similarly displaying the team’s strengths, the firm successfully represented Crocs, Inc in a series of both patent infringement claims asserted by Crocs themselves, and the team concurrently dismissing counterclaims spanning antitrust, tortious interference, and false advertising. Matthew Wolf  in Washington DC is the co-chair of the intellectual property practice, often acting as lead trial counsel and consistently successful across district courts, the ITC, and appellate courts. Based in Chicago, Dina Hayes also co-chairs the group, with extensive experience in multi-patent and multiple-party patent litigation. The team has seen substantive growth, with Jessica Kaiser joining the Denver office from the US Patent and Trademark Office in March 2022, and Abigail Struthers from Sandoz in April 2022.

The intellectual property team at Baker Botts L.L.P. has expertise spanning all industries, with in-depth knowledge of litigation strategy and the full range of IP issues. While acting for clients across a range of industries, the expertise of the team lies primarily in tech, acting for prominent tech companies including Samsung Electronics, Lyft, AT&T, Dell Inc and LG Electronics. Robert Scheinfeld in New York co-chairs the intellectual property department alongside Christa Brown-Sanford in Dallas. Focusing on IP litigation, Douglas Kubehl  in Dallas and Roger Fulghum in Houston lead the firmwide practice. ‘Gifted trial attorney’ Hopkins Guy is another key lawyer in the team, based in the firm’s Palo Alto office.

The intellectual property litigation team at Cooley LLP remains active in tech and life-science-related litigation, representing leading companies domestically and internationally. The team is adept at succeeding in all stages of long-running litigation, and has in-depth knowledge of computer hardware, software, pharma, medical devices, and other key industry sectors. The strength of the team is demonstrated through their client list, containing the likes of Facebook/Meta, Snap Inc, and Qualcomm. Steve Smith is the head of the team, based in Washington DC, with extensive first chair trial experience and regularly advising leading tech companies. Heidi Keefe is another key lawyer in the team – a first chair litigator based in Palo Alto with extensive tech sector expertise.

The intellectual property litigation team at Goodwin frequently represents innovators and creators of generics in pharma and biotech-related litigation, seeing success in significant federal circuit and Supreme Court cases. In addition to pharma-related expertise, the tech industry is another area of strength, with the firm regularly involved in high-profile, innovative cases within the space. The strength of the practice is clearly demonstrated through a client list, including Amneal Pharmaceuticals and Teva Pharmaceuticals all on the life sciences side, and IBM, CommScope, and Samsung displaying strong tech expertise. Brett Schuman leads the team out of San Francisco, alongside Daryl Wiesen based in the firm’s Boston office. Noted practitioners within the team include Elaine Blais, with experience across all stages of patent litigation, and PJ McCarthy with specialist knowledge in complex tech related disputes, particularly within computer, electronics, and mechanical arts. Naomi Birbach, with extensive experience in Hatch-Waxman linked generic drug litigation, is also integral to the team.

The intellectual property team at Morgan, Lewis & Bockius LLP handles high-stakes multijurisdictional litigation and administrative proceedings for clients in a broad range of industry sectors, with the firm offering expertise in life sciences, tech, oil and gas, marine, and consumer products. Key team members include Chicago-based Michael Abernathy and Krista Vink Venegas who co-head the IP life sciences disputes practice, Jason White, also based in Chicago, who co-leads the IP tech disputes practice of the firm, alongside Michael Lyons, based in Silicon Valley, and John Gorman in Wilmington.

The intellectual property and technology department at O'Melveny & Myers LLP contains a full-service patent litigation team, acting for clients from District Coasts to the International Trade Commission, to the Federal Circuit. The strength of the team largely lies in tech-related companies, representing Samsung and Google in numerous cases during 2022, as well as life science and Hatch-Waxman related cases.the reach of the team has grown, with expansion in Texas to include offices in Austin, Dallas, and Houston, aided by the expertise of Tim Durst in the Dallas office. Ryan Yagura of the firm’s Los Angeles office is the head of the team, with Lisa Pensabene in New York acting as the lead of pharma sector patent litigation.

The patent litigation team at Orrick, Herrington & Sutcliffe LLP has continued to secure impressive victories for a wide range of clients in 2022, including for Micron in the Federal Circuit, Microchip in the Western District of Texas, and Carnival in inter partes review proceedings. The practice has grown significantly, with the arrival in Los Angeles of David Gindler, Gary Frischling, Lauren Drake, and John Lu in November 2022 from Milbank. Clement Seth Roberts in San Francisco co-heads the team alongside Los Angeles-based Alyssa Caridis, who frequently handles complex patent and copyright litigation, open-source licensing, and IP counseling. Silicon Valley-based litigators Jason Lang and Travis Jensen are integral lawyers in the team.

The intellectual property litigation practice at Venable LLP acts frequently for leading companies in the life sciences, software, electronic, and industrial sectors, providing a full spectrum of services for these clients. Particularly strong in the pharma litigation space, the team represents innovative pharma companies, manufacturers of medical devices, and medical-related products. Based in New York, Dominick Conde, Frank Gasparo, Michael Sandonato, Scott Reed, and William E Solander all form part of the leadership, with Gasparo and Sandonato focusing on tech-related IP litigation, and Reed and Solander operating on the life sciences side. In Washington DC, Justin Pierce and Megan Woodworth also lead the team, with the latter focusing on tech sector work, while the other head of the team is Chicago-based Timothy Carroll.

The team at Weil, Gotshal & Manges LLP handles intellectual property disputes for its clients nationally, often working on high-stakes patent litigation in federal district courts, at the Federal Circuit, the International Trade Commission, and US Patent Office. Members of the team are well-versed in a wide range of industries, with many of the attorneys possessing technical and scientific college degrees. New York-based Elizabeth Weiswasser co-heads the team, a leading patent litigator on matters across biological, pharma, chemical, medical devices, and life sciences sectors in general. Edward Reines is the second head of the team, based in Silicon Valley. with extensive expertise in litigating complex patent cases in the techn and life science industries.

The intellectual property litigation team at ArentFox Schiff regularly acts on precedent-setting cases, combining in-depth technological knowledge with trial expertise. In addition to representing major generic pharma companies, the team also acts for defendants in proceedings brought by patent trolls related to software, hardware, and electronic equipment. The team has nationwide capabilities, and has continued to expand its work on patent portfolio review, compounder litigation, and patent and antitrust law intersections. Janine Carlan leads the team, a Washington DC-based patent litigator with deep experience and expertise in Hatch-Waxman and ITC section 337 cases. Sailesh Patel, based in Chicago, is the team’s co-leader, representing some of the world’s leading generic pharma companies, including Lupin Limited, Sun Pharmaceuticals, and Glenmark Pharmaceuticals, as well as leading tech clients. Also in Chicago, Imron Aly and Kevin Nelson are both key figures in the team, with a focus on patent infringement litigation.

Intellectual property is an integral practice area at Cravath, Swaine & Moore LLP, with a team of IP practitioners who are adept at handling matters involving patents, trade secrets, copyrights, and trademarks, as well as commercial litigation related to IP matters including antirust claims. In addition to national IP work, the team is capable of advising on global strategy, and benefits from close collaboration with other departments in the firm, including corporate and broader commercial litigation. Keith Hummel  and David Kappos co-chair the practice out of the firm’s New York office, regularly acting on complex patent litigation. In the same office, Sharonmoyee Goswami is integral to the team, as the go-to attorney for Alarm.com and often representing Abiomed.

The patent litigation team at Fenwick & West LLP advises companies on multi-million dollar tech and life science matters, with an in-depth understanding of artificial intelligence, cloud computing, and other key issues. Litigators at the firm defend patents for leading life science and tech companies including Amazon, Dropbox, Google, Meta Platforms, and Amazon. Robert Counihan is the co-chair of the patent litigation group, based in New York and leading on several complex cases including for Novo Nordisk and CSafe Global. Silicon Valley-based Saina Shamilov also leads the team, a successful trial lawyer who has seen high-profile successes for Amazon and Netflix.

The intellectual property litigation team at Kasowitz Benson Torres LLP acts for prominent tech and pharma companies, regularly representing both plaintiffs and defendants. The team’s extensive experience extends across Hatch-Waxman-related matters and complex patent infringement matters for domestic and international pharma companies, with a standout case being the firm’s representation of Fintiv in its precedent-setting case against Apple. Based in Silicon Valley, Jonathan Waldrop leads the team, frequently representing blue-chip tech companies including Google, Samsung, Adobe, and LG. In the same office, Darcy Jones and Marcus Barber are invaluable members of the team.

The patent litigation team at Knobbe Martens Olson & Bear LLP represents clients in litigation related to life sciences, spanning biotech, medical devices, and pharma, and electrical, semiconductor, and computer technology litigation, with a number of attorneys in the team with computer science or electrical engineering related degrees. Hatch-Waxman litigation is  a particular specialty of the firm, often advising the largest and most successful generic pharmaceutical companies including Fisher & Paykel Healthcare Limited, Fox Chase Cancer Center, Masimo Corporation, and Edwards Lifesciences. Based in Irvine, Sheila Swaroop and Michael Friedland co-head the team, with experience spanning a wide range of industries. Based in Seattle, Carol Pitzel Cruz is another key figure in the team, highly skilled at representing generics in ANDA litigations under the Hatch-Waxman Act.

The patent litigation practice at Mayer Brown represents plaintiffs and defendants from a range of Fortune 500 companies in matters across all industries, including software and hardware, pharma, and biotech. The team has defended patent lawsuits in federal, district, and appellate courts nationwide, including the US Supreme Court, the US Patent Office Board of Appeals and Interferences, and the International Trade Commission. The team represents major tech companies and innovator pharma companies, as well as Fortune 100 companies in cases involving patents from all areas. Operating out of New York, Lisa Ferri is the head of the team, frequently acting as first chair for high-profile companies in the pharma, biotech, and medical device industries. In Washington DC, Jamie Beaber and James “Tripp” Fussell are integral members of the team.

The intellectual property team at McDermott Will & Emery LLP conducts complex IP litigation nationally and internationally, often securing victories in federal district and appellate courts, as well as appearing before the Patent Trial and Appeal Board. The group particularly excels in the healthcare, pharma and life sciences area, acting for the likes of Alnylam Pharmaceuticals, Amgen, Aurinia Pharmaceuticals, United Therapeutics, and Mylan Pharmaceuticals. Operating out of Silicon Valley, William (Bill) Gaede is the global head of the intellectual property practice group, with experience litigating life science technologies including antibodies, proteins, small molecules, and diagnostics. Douglas Carsten co-heads the team, leading the life sciences practice group out of Orange County.

The patent litigation practice at McKool Smith continues to significantly expand, with Ryan McBeth joining in January 2022 from Bracewell LLP, Alfonso Chan, Ari Rafilson, and William Ellerman joining in July and August 2022 from The Shore Firm, and Christina Ondrick and Blair Jacobs from Paul Hastings LLP in July 2022. The team acts for leading tech companies across industries such as Ericsson, Nokia, AT&T, PanOptis, and WiLAN. David Sochia in Dallas co-heads the team, focusing on high-stakes patent litigation, alongside Blair Jacobs in Washington DC. Both based in Dallas, Nicholas Mathews and Warren Lipschitz are both key attorneys in the team.

The intellectual property team at Norton Rose Fulbright US LLP acts across a wide range of industry sectors, including tech, consumer markets, financial institutions, energy, infrastructure, transport, life sciences, and healthcare. The group regularly advises key clients such as Qualcomm on IP-related matters, particularly focusing on tech and patent issues, and recently represented Qualcomm in six inter partes reviews proceedings filed by Apple and Intel. Integrated with its international IP platform, the team is further noted for handling a number of global disputes. Daniel Leventhal, based in Houston, is the head of IP disputes at the firm, joined by Jim Repass in the same office and Timothy M Kenny in Minneapolis.

The intellectual property department at Ropes & Gray LLP has national and global capabilities, trying cases frequently in all major patent litigation forums including district courts, the US Patent and Trademark Office, and US Court of Appeals for the Federal Circuit. A standout mandate for the team is its representation of LG Electronics in a number of complex patent litigations, including a ten-patent case brought by ParkerVision. Steven Pepe, based in the firm’s New York office,  is the chair of the firm’s IP litigation practice, with extensive experience litigating patent cases in almost all of the notable patent jurisdictions. Silicon Valley-based James Batchelder is a key attorney in the group, acting on behalf of prominent international tech clients.

Akin offers a team of attorneys with extensive experience in all aspects of intellectual property-related litigation, and are highly active in cases in federal district courts. Clients of the team include Fortune 500 companies, multinational corporations, research foundations, and government agencies. The breadth of the team’s capabilities are evident through its work for Boston Scientific against Nevro Corp, spanning multiple patent infringement claims, petitions before the Patent Trial and Appeals Board, and appeals to the Federal Circuit. Based in Philadelphia, Steven Maslowski is the head of the team, acting as first chair for many of the team’s most prominent clients. Cono Carrano leads the Washington DC IP group, with vast experience in semiconductors, electronics, software, and wireless tech. Also based in DC, Julius Chen, Rachel Elsby, Andrew Holtman, and Brandon Rash are key figures.

The intellectual property litigation team at BakerHostetler appears in courts throughout the country, ranging from Delaware to Texas, and Virginia to California, as well as in private mediations and arbitrations, with Abbreviated New Drug Applications a particular strength of the group. Philadelphia-based Daniel Goettle and Cincinnati-based Kevin Kirsch co-lead the national patent litigation team. In Chicago, Leif R. Sigmond Jr. is the firmwide co-chair of the patent litigation group, with long-standing experience in high stakes IP litigation. In Washington DC, Mark Tidman is another head of the team.

The intellectual property group at Dechert LLP works on international IP disputes including global pharma assets, with experience in numerous US district courts along with advising on cases internationally. Numerous members of the practice possess advanced degrees in scientific and technical backgrounds. Martin Black leads the national patent litigation team out of the firm’s Philadelphia office, alongside Austin-based Jeffrey B. Plies. Operating out of New York, Katherine Helm frequently represents innovator pharma and biotech companies, utilizing her neuroscience doctorate.

The intellectual property team at Dickinson Wright PLLC handles patent infringement claims and post grant review proceedings in state and federal courts state-wide. Particular expertise of the team lies in relation to the import and domestic sales of foreign manufactured infringing products, but the group is active across a wide range of industry sectors, from trucking to manufacturing to gaming. Based in Ann Arbor, Philip Rettig and John Artz lead the team, alongside Frank Long in Phoenix.

 

The intellectual property team at Duane Morris LLP combine an in-depth knowledge of patent law with an aptitude for science and tech, representing clients in defending patent infringement claims. Areas of expertise include abbreviated new drug applications, advanced materials, artificial intelligence, aviation, biotech, and wireless communication systems. Based in Atlanta, Woody Jameson and Matthew Gaudet lead the team alongside Anthony Fitzpatrick in Boston, and Patrick McPherson in Washington DC. In the firm’s Palo Alto office, Stuart Bartow and Philip Woo are integral to the team, often acting as lead counsel for clients.

The patent litigation team at Eversheds Sutherland advises leading companies nationally and internationally on the full range of high-value patent litigation. The team routinely handles multi-district disputes between competitors, and represents petitioners and patent owners in US Patent Trial and Appeal Board proceedings, as well as Federal Circuit appeals. Intellectual property issues acted on by the team include consumer products, medical devices, energy, biotech, generic pharma, automotive, manufacturing, chemicals, healthcare, media, software, and TMT, amongst others. Notable clients of the team include Lumen Technologies, ESET, and Workplace Technologies. Peter Pappas, the co-head of global intellectual property leads, based in the firm’s Atlanta office, alongside San Diego-based Jose L Patino. Also based in San Diego, Nicola Pisano, Justin Gray, and Scott Penner all bring extensive trial experience to the team.

The intellectual property and tech patent litigation department at Greenberg Traurig, LLP acts on cases in all major patent jurisdictions, with a particularly strong record at the Court of Appeals for the Federal Circuit. The team offers broad expertise on technical issues with a global platform, advising major clients including Teva Pharmaceuticals and Amneal Pharmaceuticals on complex, business-critical matters. Based in New York, Scott Bornstein and Joshua Raskin co-head the team, alongside Chicago-based Richard Harris. Based in New York Rose Cordero Prey is a key member of the team. Allan Kassenoff has left the firm.

The IP litigation team at K&L Gates is a full-service practice with standout global integration, allowing the firm to handle complex cross-border intellectual property matters in conjunction with international experts. The team acts across various industries, including chemical and mechanical engineering, electrical engineering, and pharmacology. Theo Angelis, a talented trial lawyer operating out of Seattle, is the practice group coordinator for the IP litigation practice. Christina Goodrich, the managing partner of the firm’s Los Angeles office, and Benjamin Weed, a Chicago-based patent attorney with a computer science background both also lead the team.

 

Litigation boutique MoloLamken LLP has a thriving intellectual property practice, handling complex intellectual property matters before federal courts of appeals and the Supreme Court, working on precedent-setting cases. The group covers the gamut of IP linked litigation, from infringement verdicts, to defending favorable PTAB decisions, to defending exclusion orders. The department has many impressive clients, including Musee du Louvre, Wagner Aeronautical, Express Mobile, Ericcson, and Amgen. In Washington DC, Jeffrey Lamken and Michael Pattillo lead the team joined by Ben Quarmby in New York.

Chicago-based patent litigation boutique Rakoczy Molino Mazzochi Siwik LLP represents international leading producers of generic drugs, and is regularly involved in high-profile proceedings on a national basis. William Rakoczy, a founding partner of the firm, leads the team, recently defending a win for Alkem in the Federal Court. Also a founding partner of the firm and the firm’s co-managing partner, Paul Molino co-leads the team, with extensive experience of ground-breaking litigation.

The intellectual property and technology litigation group at Robins Kaplan LLP acts frequently on high stakes IP and tech-related disputes, representing a wide range of clients including tech-oriented companies, emerging companies, and individual inventors, authors, and developers. The practice group works across diverse technologies, representing clients in issues such as microprocessor design, telecoms equipment, therapeutic tech, and imaging hardware. Experienced first-chair trial lawyer Christopher Larus chairs the group, based in the firm’s Minnesota office, with experience in courts across the country. Also based in Minnesota, Jake Holdreith and Cyrus Morton are integral to the team.

The intellectual property department at Willkie Farr & Gallagher LLP represents and counsels clients in complex sophisticated intellectual property litigation surrounding tech, life sciences, manufacturing, pharma, biotech, energy, automotive, and electronics. The team is particularly adept at litigating Hatch-Waxman cases in the pharma field, largely acting on biosimilar matters. The group continues to grow, with Genevieve Dorment joining the New York office from Simpson Thacher & Bartlett LLP in May 2022, and Barrington Dyer joining in San Francisco from Polsinelli PC in February 2022. Based in New York, Thomas Meloro is the chair of the intellectual property, with Sara Tonnies Horton and Krista Schwartz co-chairing the patent and broader IP litigation team out of Chicago and San Francisco respectively. Washington DC-based Indranil Mukerji is the head of tech-related patent litigation.